Skip to main content

Advertisement

Log in

Cardiac imaging of a patient with unusual presentation of granulomatosis with polyangiitis: A case report and review of the literature

  • Case Presentation Corner
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

Recent evidence suggests that cardiac involvement in patients with granulomatosis with polyangiitis (GPA) occurs more frequently than previously reported. Multimodality cardiac imaging is gaining attention in the diagnosis, prognostication, and follow-up of such patients; however, the data remain scarce.

Results

2D-TTE was useful for initial screening; while both cardiac magnetic resonance imaging and 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18FDG-PET/CT) metabolic imaging with rubidium-82 PET perfusion imaging were useful for characterization of myocardial disease. 18FDG-PET/CT was very useful for the follow-up of cardiac disease activity following treatment.

Conclusion

18FDG-PET/CT is sensitive for the detection of cardiac involvement by GPA and is useful for the tissue characterization and follow-up of disease activity following treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

c-ANCA:

c-Anti-neutrophil cytoplasmic antibody

CMR:

Cardiac magnetic resonance

2D-TTE:

Two-dimensional transthoracic echocardiography

18FDG-PET/CT:

18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography

GPA:

Granulomatosis with polyangiitis

LGE:

Late gadolinium enhancement

LV:

Left ventricle

LVEF:

Left ventricular ejection fraction

PET:

Positron emission tomography

STIR:

T2-weighted short-tau inversion recovery

References

  1. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475-87.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Yates M. Watts R. ANCA-associated vasculitis Clin Med (Lond). 2017;17(1):60-4.

    PubMed  PubMed Central  Google Scholar 

  3. Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485-507.

    Article  PubMed  Google Scholar 

  4. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187-226.

    Article  PubMed  Google Scholar 

  5. Silvera S, Palangié E, Guillevin L, Hendaoui L, Legmann P. Imaging features of granulomatosis with polyangiitis (Wegener’s). In: Hendaoui L, Stanson AW, Bouhaouala MH, Joffre F, editors. Systemic vasculitis imaging features. Springer Nature: Basel; 2018. p. 269-78.

    Google Scholar 

  6. Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun. 2014;48-49:94-8.

    Article  CAS  PubMed  Google Scholar 

  7. Relle M, Fohr B, Fasola F, Schwarting A. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3. Mol Cell Probes. 2016;30(6):366-73.

    Article  CAS  PubMed  Google Scholar 

  8. Florian A, Slavich M, Blockmans D, Dymarkowski S, Bogaert J. Cardiac involvement in granulomatosis with polyangiitis (Wegener granulomatosis). Circulation. 2011;124(13):e342-4.

    Article  PubMed  Google Scholar 

  9. Saleh Farghaly HR, Alqarni AO, Nasr HA. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Involvement in Widespread Granulomatosis with Polyangiitis (Wegener’s Granulomatosis). Indian J Nucl Med. 2019;34(2):153-6.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener’s granulomatosis and the heart. Br Heart J. 1994;71(1):82-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Pugnet G, Gouya H, Puechal X, Terrier B, Kahan A, Legmann P, et al. Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive patients. Rheumatology (Oxford). 2017;56(6):947-56.

    Article  CAS  PubMed  Google Scholar 

  12. Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015;199:170-9.

    Article  CAS  PubMed  Google Scholar 

  13. Miszalski-Jamka T, Szczeklik W, Nycz K, Sokolowska B, Gorka J, Bury K, et al. Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener’s). Echocardiography. 2012;29(7):803-9.

    Article  PubMed  Google Scholar 

  14. McGeoch L, Carette S, Cuthbertson D, Hoffman GS, Khalidi N, Koening CL, et al. Cardiac Involvement in Granulomatosis with Polyangiitis. J Rheumatol. 2015;42(7):1209-12.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64(2):542-8.

    Article  CAS  PubMed  Google Scholar 

  16. Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19-27.

    Article  PubMed  Google Scholar 

  17. Al-Habbaa A, Rawla P, Morra ME, Abotaha AA, Sakr EE, Abdo Shehata MA, et al. Valvular involvement in granulomatosis with polyangiitis: Case report and systematic review of literature. Echocardiography. 2018;35(9):1456-63.

    Article  PubMed  Google Scholar 

  18. Lacoste C, Mansencal N, Ben M’rad M, Goulon-Goeau C, Cohen P, Guillevin L, et al. Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review. BMC Musculoskelet Disord. 2011;12:50.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Forstot JZ, Overlie PA, Neufeld GK, Harmon CE, Forstot SL. Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum. 1980;10(2):148-54.

    Article  CAS  PubMed  Google Scholar 

  20. Colin GC, Vancraeynest D, Hoton D, Jonard P, Gerber B. Complete heart block caused by diffuse pseudotumoral cardiac involvement in granulomatosis with polyangiitis. Circulation. 2015;132(17):e207-10.

    Article  PubMed  Google Scholar 

  21. Shakil O, Matyal R, Khabbaz K, Wang A, Mahmood F. Intracardiac Wegener’s granulomatosis. Ann Thorac Surg. 2012;94(4):e105.

    Article  PubMed  Google Scholar 

  22. Korantzopoulos P, Papaioannides D, Siogas K. The heart in Wegener’s granulomatosis. Cardiology. 2004;102(1):7-10.

    Article  PubMed  Google Scholar 

  23. Dewan R, Trejo Bittar HE, Lacomis J, Ocak I. Granulomatosis with Polyangiitis Presenting with Coronary Artery and Pericardial Involvement. Case Rep Radiol. 2015;2015:516437.

    PubMed  PubMed Central  Google Scholar 

  24. Subramanian HE, Sutaria R, Koumpouras F. The classification & diagnosis of granulomatosis with polyangiitis. The Rheumatologist. August, 2018.

  25. Kane GC, Keogh KA. Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol. 2009;21(1):29-34.

    Article  PubMed  Google Scholar 

  26. Oliveira GH, Seward JB, Tsang TS, Specks U. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc. 2005;80(11):1435-40.

    Article  PubMed  Google Scholar 

  27. Miszalski-Jamka T, Szczeklik W, Sokolowska B, Miszalski-Jamka K, Karwat K, Grzadziel G, et al. Cardiac involvement in Wegener’s granulomatosis resistant to induction therapy. Eur Radiol. 2011;21(11):2297-304.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener’s granulomatosis. J Rheumatol. 2003;30(1):80-8.

    PubMed  Google Scholar 

  29. Hazebroek MR, van Paassen P, Dennert R, Heymans S. Chapter 20: ANCA-associated vasculitis: microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss Syndrome) and granulomatosis With polyangiitis (Wegener’s granulomatosis). In: The heart in rheumatic, autoimmune and inflammatory diseases. London: Academic Press; 2017. p. 459-502.

  30. Zycinska K, Borowiec A, Zielonka TM, Rusinowicz T, Hadzik-Blaszczyk M, Cieplak M, et al. Echocardiographic Assessment in Patients with Granulomatosis with Polyangiitis. Adv Exp Med Biol. 2017;1022:27-33.

    Article  PubMed  Google Scholar 

  31. Ahn SS, Park ES, Jung SM, Song JJ, Park YB, Lee SW. Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis. Clin Rheumatol. 2017;36(12):2751-9.

    Article  PubMed  Google Scholar 

  32. Morelli S, Gurgo Di Castelmenardo AM, Conti F, Sgreccia A, Alessandri C, Bernardo ML, et al. Cardiac involvement in patients with Wegener’s granulomatosis. Rheumatol Int. 2000;19(6):209-12.

    Article  CAS  PubMed  Google Scholar 

  33. Goodfield NE, Bhandari S, Plant WD, Morley-Davies A, Sutherland GR. Cardiac involvement in Wegener’s granulomatosis. Br Heart J. 1995;73(2):110-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Guterbaum TJ, Husic M, Voss A, Dahl JS. Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation. Am J Case Rep. 2019;20:423-9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Taskesen T, Goldberg SL, Mannelli L, Rabkin D, Hawn TR, Fligner CL, et al. Granulomatosis With Polyangiitis Presenting With an Intracardiac Mass and Complete Heart Block: Enhanced Images by 3-Dimensional Echocardiography. Circulation. 2015;132(10):961-4.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Safak O, Gursul E, Polat M, Akcay F, Tuluce S, Aytemız F, et al. Wegener’s granulomatosis with cardiac involvement. International Journal of the Cardiovascular Academy. 2016;2(2):93-5.

    Article  Google Scholar 

  37. Al-Mohaissen MA, Chan KL. Echocardiography in the Assessment of Patients with Rheumatologic Diseases. Curr Cardiol Rep. 2016;18(8):72.

    Article  PubMed  Google Scholar 

  38. Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging. 2013;6(5):833-9.

    Article  PubMed  Google Scholar 

  39. Mavrogeni S, Schwitter J, van Rossum A, Nijveldt R, Aletras A, Kolovou G, et al. Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: An appraisal of the diagnostic strengths and limitations of the Lake Louise criteria. Int J Cardiol. 2018;252:216-9.

    Article  PubMed  Google Scholar 

  40. Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, et al. Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naive patients with connective tissue diseases. Int J Cardiol. 2017;236:151-6.

    Article  PubMed  Google Scholar 

  41. Miszalski-Jamka T, Szczeklik W, Sokolowska B, Karwat K, Belzak K, Mazur W, et al. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging. 2013;29(4):843-53.

    Article  PubMed  Google Scholar 

  42. Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009;61(8):1121-9.

    Article  CAS  PubMed  Google Scholar 

  43. Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008;67(7):1030-3.

    Article  CAS  PubMed  Google Scholar 

  44. Arlet JB, Le Thi Huong D, Marinho A, Cluzel P, Wechsler B, Piette JC. Arterial aneurysms in Wegener’s granulomatosis: case report and literature review. Semin Arthritis Rheum. 2008;37(4):265-8.

    Article  PubMed  Google Scholar 

  45. Amin S, Hossain R, Jeudy J, Frazier AA, White C. A Sensible Approach to Diagnosing Cardiac Aneurysms, Pseudoaneurysms and Common Mimickers. J Thorac Imaging. 2018;33(6):W39-47.

    Article  PubMed  Google Scholar 

  46. Paul M, Schafers M, Grude M, Reinke F, Juergens KU, Fischbach R, et al. Idiopathic left ventricular aneurysm and sudden cardiac death in young adults. Europace. 2006;8(8):607-12.

    Article  PubMed  Google Scholar 

  47. Hoey ET, Nagra I, Ganeshan A. Cardiac aneurysms and diverticula: magnetic resonance and computed tomography appearances. Curr Probl Diagn Radiol. 2011;40(2):72-84.

    Article  PubMed  Google Scholar 

  48. De Geeter F, Gykiere P. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis. Hell J Nucl Med. 2016;19(1):5-6.

    PubMed  Google Scholar 

  49. Jiemy WF, Heeringa P, Kamps J, van der Laken CJ, Slart R, Brouwer E. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospects. Autoimmun Rev. 2018;17(7):715-26.

    Article  PubMed  Google Scholar 

  50. Hyafil F, Rischpler C, Nekolla S, Le Guludec D, Schwaiger M. Emerging clinical applications for PET/MR in the field of cardiovascular imaging. Médecine Nucléaire. 2016;40(1):11-9.

    Article  Google Scholar 

  51. Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull. 2016;120(1):55-74.

    Article  CAS  PubMed  Google Scholar 

  52. Slart RHJA, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250-69.

  53. Elefante E, Bond M, Monti S, Lepri G, Cavallaro E, Felicetti M, et al. One year in review 2018: systemic vasculitis. Clin Exp Rheumatol. 2018;36(Suppl 111(2)):12-32.

    PubMed  Google Scholar 

  54. Rischpler C, Woodard PK. PET/MR Imaging in Cardiovascular Imaging. PET Clin. 2019;14(2):233-44.

    Article  PubMed  Google Scholar 

  55. Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017;24(1):86-99.

    Article  PubMed  Google Scholar 

  56. Bhambhvani P. Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography. J Nucl Cardiol. 2017;24(1):100-2.

    Article  PubMed  Google Scholar 

  57. Soussan M, Brillet PY, Nunes H, Pop G, Ouvrier MJ, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20(1):120-7.

    Article  PubMed  Google Scholar 

  58. von Olshausen G, Hyafil F, Langwieser N, Laugwitz KL, Schwaiger M, Ibrahim T. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging. Circulation. 2014;130(11):925-6.

    Article  Google Scholar 

  59. De Geeter F, Gykiere P. (18)F-FDG PET imaging of granulomatosis with polyangiitis -Wegener’s Syndrome. Hell J Nucl Med. 2016;19(1):53-6.

    PubMed  Google Scholar 

  60. Kemna MJ, Vandergheynst F, Voo S, Blocklet D, Nguyen T, Timmermans SA, et al. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine (Baltimore). 2015;94(20):e747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Ito K, Minamimoto R, Yamashita H, Morooka M, Okasaki M, Mimori A, et al. 18F-FDG PET/CT findings preceded elevation of serum proteinase 3 antineutrophil cytoplasmic antibodies in Wegener granulomatosis. Clin Nucl Med. 2014;39(1):e67-8.

    Article  PubMed  Google Scholar 

  62. Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M, et al. Evaluation of Wegener’s granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med. 2013;27(3):209-16.

    Article  PubMed  Google Scholar 

  63. Aydin M, Akkoyunlu ME, Yakar F, Ergul N, Sezer M. Intense FDG uptake on PET/CT in the upper and lower respiratory system indicative of Wegener’s granulomatosis. Rev Esp Med Nucl Imagen Mol. 2014;33(1):32-5.

    CAS  PubMed  Google Scholar 

  64. Ozmen O, Tatci E, Gokcek A, Koksal D, Dadali Y, Ozaydin E, et al. Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener’s granulomatosis. Ann Nucl Med. 2013;27(10):907-15.

    Article  CAS  PubMed  Google Scholar 

  65. Soussan M, Abisror N, Abad S, Nunes H, Terrier B, Pop G, et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev. 2014;13(2):125-31.

    Article  PubMed  Google Scholar 

  66. Ozdemir E, Yildirim-poyraz N, Senturk A, Uz E, Keskin M, Yüksel L, et al. 18F-FDG PET/CT Findings of a Patient with Wegener’s Granulomatosis Before and After Therapy. Molecular Imaging and Radionuclide Therapy. 2015;24(Supplement 1):1-3.

    Article  Google Scholar 

  67. Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Muller GA, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis. 2004;63(11):1507-10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Einspieler I, Thurmel K, Pyka T, Eiber M, Wolfram S, Moog P, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012-24.

    Article  CAS  PubMed  Google Scholar 

  69. Bouhaouala MH, Hendaoui L, Stanson AW, Joffre F. Medical Imaging Investigation of Vasculitis. In: Stanson AW, Bouhaouala MH, Joffre F, editors. Hendaoui L. Systemic Vasculitis Imaging Features. Switzerland AG.: Springer Nature; 2018. p. 43-9.

    Google Scholar 

  70. Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-7.

    Article  PubMed  Google Scholar 

  71. Danve A, O’Dell J. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis. Int J Rheum Dis. 2015;18(7):714-24.

    Article  CAS  PubMed  Google Scholar 

  72. Asawaeer M, Sayyed S, Chatzizisis YS. A rare case of granulomatosis with polyangiitis-induced burnout cardiomyopathy: role of combined viability and metabolic imaging. Eur Heart J Cardiovasc Imaging. 2018;19(5):584.

    Article  PubMed  Google Scholar 

  73. Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas T, Kolovou G, et al. Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases. JACC Cardiovasc Imaging. 2017;10(11):1387-96.

    Article  PubMed  Google Scholar 

  74. Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M. Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. Front Med (Lausanne). 2018;5:26.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L. Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med. 2018;5(1):e000265.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Moncayo R, Kowald E, Schauer N, Pachinger O, Schmuth M, Fritsch P, et al. Detection of myocardial involvement in systemic lupus erythematosus: mismatch between normal perfusion scans with 201Thallium and pathological 18FDG uptake. International Angiology. 2001;20(4):314-21.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by the Cardiovascular Disease in Women Research Chair at the Princess Nourah bint Abdulrahman University (Grant No. CDW-2019-02).

Disclosure

Rabah Al-Mehisen, Khalid Alnemri, and Maha Al-Mohaissen have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maha Al-Mohaissen MBBS, SBIM, MRCPUK.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (MPEG 737 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Mehisen, R., Alnemri, K. & Al-Mohaissen, M. Cardiac imaging of a patient with unusual presentation of granulomatosis with polyangiitis: A case report and review of the literature. J. Nucl. Cardiol. 28, 441–455 (2021). https://doi.org/10.1007/s12350-019-01809-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-019-01809-6

Keywords

Navigation